Last reviewed · How we verify

NCT03550846: TENNIS

Clinical and Radiological Investigation of a New Spinal Fixateur Interne (Ennovate®)

Completed Last updated 17 January 2023
What this trial tests

trial in Spinal Fusion in 188 participants. Completed in 18 November 2022.

Timeline
12 April 2018
Primary endpoint
27 May 2021
18 November 2022

Quick facts

Lead sponsorAesculap AG
StatusCompleted
Study typeOBSERVATIONAL
Enrollment188
Start date12 April 2018
Primary completion27 May 2021
Estimated completion18 November 2022
Sites7 locations across Germany

Conditions studied

Sponsor

Aesculap AG — full company profile →

Who can join

18 and older, any sex, with Spinal Fusion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is planned and conducted to document all patients in the participating Centers, who are treated with the CE-marked product, the Fixateur Ennovate®, regardless of the diagnosis or indication. Data on performance and safety of the product, validated patient based questionnaires (Oswestry Disability Index, ODI) as well as the satisfaction of the patients in general are captured.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Spinal Fusion

Currently open trials in the same condition.

Other Aesculap AG trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03550846.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing